Dr. Sharma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Summary
- Urologic Oncology Fellow doing a hybrid fellowship: health services research at UCLA and clinical urologic oncology at Mayo Clinic. Interest in practicing academic Urologic Oncology and addressing health economic problems within surgery.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Minimally Invasive Urologic Surgery, 2019 - 2022
Ronald Reagan UCLA Medical CenterFellowship, Health Services Research, 2019 - 2021- Mayo Clinic College of Medicine and Science (Rochester)Residency, Urology, 2014 - 2019
Northwestern University The Feinberg School of MedicineClass of 2014
Northwestern UniversityBA, Economics, Magna Cum Laude, 2007 - 2010
Certifications & Licensure
MN State Medical License 2015 - 2025
CA State Medical License 2019 - 2021
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- Intraoperative Tranexamic Acid in Radical Cystectomy: Impact on Bleeding, Thromboembolism, and Survival Outcomes.Mohamed E Ahmed, Jack R Andrews, Ahmed M Mahmoud, Giuseppe Reitano, Prabin Thapa
The Journal of Urology. 2024-12-02 - 2 citationsRelative impact of lymph-node metastasis and seminal vesical invasion on oncologic outcomes following radical prostatectomy.Rodrigo Rodrigues Pessoa, Reza Nabavizadeh, Paras Shah, Igor Frank, Mathew Tollefson
Prostate Cancer and Prostatic Diseases. 2024-12-01 - Evaluation of American Urological Association Renal Cell Carcinoma Risk Groups for Chromophobe Renal Cell Carcinoma.Cameron J Britton, Vidit Sharma, Andrew Zganjar, Christine M Lohse, John C Cheville
Urology. 2024-12-01
Journal Articles
- Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results from the Internationa...Michael J Zelefsky, Matthew R Cooperberg, Brian J Davis, Eric M Horwitz, Martha K Terris, Christopher L Amling, Christopher J Kane, Curtiland Deville, Theodore L Dewee..., JAMA Oncology
- Positive Pelvic Lymph Nodes in Prostate Cancer Harbor Immune Suppressor Cells To Impair Tumor-reactive T CellsVidit Sharma, Haidong Dong, Eugene Kwon and R. Jeffrey Karnes, EU Focus, 9/22/2016
Press Mentions
Don't Remove Bladder for Localized Muscle-Invasive CancerMay 26th, 2023- Lack of PSA Screening Increased Metastatic Prostate CancerMarch 20th, 2021
- ASCO GU 2021: Cost-Effectiveness Analysis of Pembrolizumab for BCG-Unresponsive Carcinoma in Situ of the BladderFebruary 13th, 2021
- Join now to see all
Professional Memberships
- Member
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
